世界の眼科用医薬品・医療機器市場は、2024年に約966億1,000万米ドルと評価され、2025年から2035年にかけて9.00%という驚異的な年平均成長率（CAGR）で拡大すると見込まれています。その原動力は、視覚障害の有病率の加速、早期診断への意識の高まり、そして治療技術の急速な進歩です。加齢に伴う黄斑変性、緑内障、白内障といった眼疾患の急増に加え、糖尿病関連の眼科合併症の世界的な増加も、医薬品と医療機器の両方による治療への需要を刺激しています。市場の成長は、医療費の増加、保険適用範囲の拡大、そしてより迅速な回復と患者の快適性向上を約束する低侵襲手術ソリューションへの移行によっても支えられています。さらに、新しい生物製剤、徐放性薬物送達システム、AI支援診断ツールの研究が勢いを増すにつれ、市場では眼科疾患の予防、診断、管理の方法にパラダイムシフトが起こりつつあります。
眼科における個別化医療への世界的な需要の高まりを受け、大手製薬会社や医療機器メーカーは研究開発への投資を強化しています。炎症性および変性性眼疾患の特定の経路を標的とした医薬品の革新、次世代眼内レンズ、低侵襲性緑内障手術デバイスは、効果的な治療選択肢の幅を広げています。国際失明予防機関（IAP）のデータによると、世界中で約22億人が何らかの視力障害を抱えており、この数は高齢化と生活習慣に起因する眼疾患により増加すると予測されています。さらに、特に医療サービスが不足している地域において、遠隔眼科医療の普及が進んでいることで、タイムリーな介入が可能になり、市場へのアクセスが向上しています。しかしながら、治療費の高騰、規制当局の承認期間の厳格化、そしてリソースの限られた環境における専門医の確保が市場拡大の妨げとなっており、一部地域では導入率が低下する可能性があります。
地域別では、北アメリカは、堅牢な医療インフラ、患者の高い意識、そして世界有数の眼科専門製薬企業および医療機器企業の存在に支えられ、予測期間を通じて市場における優位性を維持すると予想されます。この地域の有利な償還枠組みと、高度な診断・外科技術の広範な導入は、同地域の市場における地位をさらに強化します。ヨーロッパは、患者の安全を重視する厳格な規制、視力矯正機器の継続的な革新、そして専門眼科クリニックの拡大に牽引され、これに追随しています。一方、アジア太平洋地域は、急速な都市化、近視や糖尿病網膜症の増加、そして中国やインドなどの人口過密国における医療アクセスの拡大を背景に、最も高い成長率を記録すると予測されています。多国籍企業と地域の医療機関との戦略的連携、そして政府主導の眼科保健プログラムが相まって、地域全体で医薬品と医療機器の導入が加速すると期待されます。
本調査の目的は、近年における様々なセグメントおよび国における市場規模を定義し、今後数年間の価値を予測することです。本レポートは、調査対象国における業界の定性的および定量的側面の両方を網羅するように設計されており、市場の将来の成長を決定づける推進要因や課題といった重要な側面についても詳細な情報を提供しています。さらに、利害関係者が投資できるマイクロ市場における潜在的な機会、そして主要プレーヤーの競争環境と製品提供の詳細な分析も盛り込んでいます。
目次
Table of Content
Chapter 1. Global Ophthalmology Drugs & Devices Market Report Scope & Methodology
1.1. Research Objective
1.2. Research Methodology
1.2.1. Forecast Model
1.2.2. Desk Research
1.2.3. Top Down and Bottom-Up Approach
1.3. Research Attributes
1.4. Scope of the Study
1.4.1. Market Definition
1.4.2. Market Segmentation
1.5. Research Assumption
1.5.1. Inclusion & Exclusion
1.5.2. Limitations
1.5.3. Years Considered for the Study
Chapter 2. Executive Summary
2.1. CEO/CXO Standpoint
2.2. Strategic Insights
2.3. ESG Analysis
2.4. Key Findings
Chapter 3. Global Ophthalmology Drugs & Devices Market Forces Analysis
3.1. Market Forces Shaping The Global Ophthalmology Drugs & Devices Market (2024-2035)
3.2. Drivers
3.2.1. Rising prevalence of vision disorders and aging demographics fueling demand for drugs & devices
3.2.2. Innovation in biologics, sustained-release delivery and minimally invasive surgical devices improving treatment options
3.3. Restraints
3.3.1. High treatment and device costs along with lengthy regulatory approval timelines constraining adoption
3.3.2. Limited specialist availability and uneven access to advanced care in low-resource regions
3.4. Opportunities
3.4.1. Teleophthalmology, screening programs and public health initiatives expanding reach into underserved markets
3.4.2. Strategic collaborations, M&A and local manufacturing to accelerate commercialization in APAC and LATAM
Chapter 4. Global Ophthalmology Drugs & Devices Industry Analysis
4.1. Porter’s 5 Forces Model
4.1.1. Bargaining Power of Buyer
4.1.2. Bargaining Power of Supplier
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Forecast Model (2024-2035)
4.3. PESTEL Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top Investment Opportunities
4.5. Top Winning Strategies (2025)
4.6. Market Share Analysis (2024-2025)
4.7. Global Pricing Analysis And Trends 2025
4.8. Analyst Recommendation & Conclusion
Chapter 5. Global Ophthalmology Drugs & Devices Market Size & Forecasts by Product 2025-2035
5.1. Market Overview
5.2. Global Ophthalmology Drugs & Devices Market Performance - Potential Analysis (2025)
5.3. Drugs
5.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
5.3.2. Market size analysis, by region, 2025-2035
5.4. Devices
5.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
5.4.2. Market size analysis, by region, 2025-2035
Chapter 6. Global Ophthalmology Drugs & Devices Market Size & Forecasts by Treatment 2025-2035
6.1. Market Overview
6.2. Global Ophthalmology Drugs & Devices Market Performance - Potential Analysis (2025)
6.3. Eye Infections
6.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
6.3.2. Market size analysis, by region, 2025-2035
6.4. Allergic Conjunctivitis
6.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
6.4.2. Market size analysis, by region, 2025-2035
6.5. Dry Eyes Syndrome
6.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
6.5.2. Market size analysis, by region, 2025-2035
6.6. Red Eyes
6.6.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
6.6.2. Market size analysis, by region, 2025-2035
6.7. Inflammation
6.7.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
6.7.2. Market size analysis, by region, 2025-2035
6.8. Others
6.8.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
6.8.2. Market size analysis, by region, 2025-2035
Chapter 7. Global Ophthalmology Drugs & Devices Market Size & Forecasts by Region 2025-2035
7.1. Ophthalmology Market, Regional Market Snapshot
7.2. Top Leading & Emerging Countries
7.3. North America Ophthalmology Market
7.3.1. U.S. Ophthalmology Market
7.3.1.1. Product breakdown size & forecasts, 2025-2035
7.3.1.2. Treatment breakdown size & forecasts, 2025-2035
7.3.2. Canada Ophthalmology Market
7.3.2.1. Product breakdown size & forecasts, 2025-2035
7.3.2.2. Treatment breakdown size & forecasts, 2025-2035
7.4. Europe Ophthalmology Market
7.4.1. UK Ophthalmology Market
7.4.1.1. Product breakdown size & forecasts, 2025-2035
7.4.1.2. Treatment breakdown size & forecasts, 2025-2035
7.4.2. Germany Ophthalmology Market
7.4.2.1. Product breakdown size & forecasts, 2025-2035
7.4.2.2. Treatment breakdown size & forecasts, 2025-2035
7.4.3. France Ophthalmology Market
7.4.3.1. Product breakdown size & forecasts, 2025-2035
7.4.3.2. Treatment breakdown size & forecasts, 2025-2035
7.4.4. Spain Ophthalmology Market
7.4.4.1. Product breakdown size & forecasts, 2025-2035
7.4.4.2. Treatment breakdown size & forecasts, 2025-2035
7.4.5. Italy Ophthalmology Market
7.4.5.1. Product breakdown size & forecasts, 2025-2035
7.4.5.2. Treatment breakdown size & forecasts, 2025-2035
7.4.6. Rest of Europe Ophthalmology Market
7.4.6.1. Product breakdown size & forecasts, 2025-2035
7.4.6.2. Treatment breakdown size & forecasts, 2025-2035
7.5. Asia Pacific Ophthalmology Market
7.5.1. China Ophthalmology Market
7.5.1.1. Product breakdown size & forecasts, 2025-2035
7.5.1.2. Treatment breakdown size & forecasts, 2025-2035
7.5.2. India Ophthalmology Market
7.5.2.1. Product breakdown size & forecasts, 2025-2035
7.5.2.2. Treatment breakdown size & forecasts, 2025-2035
7.5.3. Japan Ophthalmology Market
7.5.3.1. Product breakdown size & forecasts, 2025-2035
7.5.3.2. Treatment breakdown size & forecasts, 2025-2035
7.5.4. Australia Ophthalmology Market
7.5.4.1. Product breakdown size & forecasts, 2025-2035
7.5.4.2. Treatment breakdown size & forecasts, 2025-2035
7.5.5. South Korea Ophthalmology Market
7.5.5.1. Product breakdown size & forecasts, 2025-2035
7.5.5.2. Treatment breakdown size & forecasts, 2025-2035
7.5.6. Rest of APAC Ophthalmology Market
7.5.6.1. Product breakdown size & forecasts, 2025-2035
7.5.6.2. Treatment breakdown size & forecasts, 2025-2035
7.6. Latin America Ophthalmology Market
7.6.1. Brazil Ophthalmology Market
7.6.1.1. Product breakdown size & forecasts, 2025-2035
7.6.1.2. Treatment breakdown size & forecasts, 2025-2035
7.6.2. Mexico Ophthalmology Market
7.6.2.1. Product breakdown size & forecasts, 2025-2035
7.6.2.2. Treatment breakdown size & forecasts, 2025-2035
7.7. Middle East and Africa Ophthalmology Market
7.7.1. UAE Ophthalmology Market
7.7.1.1. Product breakdown size & forecasts, 2025-2035
7.7.1.2. Treatment breakdown size & forecasts, 2025-2035
7.7.2. Saudi Arabia (KSA) Ophthalmology Market
7.7.2.1. Product breakdown size & forecasts, 2025-2035
7.7.2.2. Treatment breakdown size & forecasts, 2025-2035
7.7.3. South Africa Ophthalmology Market
7.7.3.1. Product breakdown size & forecasts, 2025-2035
7.7.3.2. Treatment breakdown size & forecasts, 2025-2035
Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Novartis AG
8.2.1. Company Overview
8.2.2. Key Executives
8.2.3. Company Snapshot
8.2.4. Financial Performance (Subject to Data Availability)
8.2.5. Product/Services Port
8.2.6. Recent Development
8.2.7. Market Strategies
8.2.8. SWOT Analysis
8.3. Alcon Inc.
8.4. Bausch + Lomb Corporation
8.5. Johnson & Johnson Vision Care, Inc.
8.6. Carl Zeiss Meditec AG
8.7. AbbVie Inc.
8.8. CooperVision, Inc.
8.9. Allergan Plc
8.10. EssilorLuxottica SA
8.11. Hoya Corporation
8.12. STAAR Surgical Company
8.13. Glaukos Corporation
8.14. Santen Pharmaceutical Co., Ltd.
8.15. Ziemer Ophthalmic Systems AG
8.16. Topcon Corporation
List of Tables
Table 1. Global Ophthalmology Drugs & Devices Market, Report Scope
Table 2. Global Ophthalmology Drugs & Devices Market Estimates & Forecasts By Region 2024-2035
Table 3. Global Ophthalmology Drugs & Devices Market Estimates & Forecasts By Product 2024-2035
Table 4. Global Ophthalmology Drugs & Devices Market Estimates & Forecasts By Treatment 2024-2035
Table 5. Global Ophthalmology Drugs & Devices Market Estimates & Forecasts By Segment 2024-2035
Table 6. Global Ophthalmology Drugs & Devices Market Estimates & Forecasts By Product—Drugs 2024-2035
Table 7. Global Ophthalmology Drugs & Devices Market Estimates & Forecasts By Product—Devices 2024-2035
Table 8. U.S. Ophthalmology Drugs & Devices Market Estimates & Forecasts, 2024-2035
Table 9. Canada Ophthalmology Drugs & Devices Market Estimates & Forecasts, 2024-2035
Table 10. UK Ophthalmology Drugs & Devices Market Estimates & Forecasts, 2024-2035
Table 11. Germany Ophthalmology Drugs & Devices Market Estimates & Forecasts, 2024-2035
Table 12. France Ophthalmology Drugs & Devices Market Estimates & Forecasts, 2024-2035
Table 13. Spain Ophthalmology Drugs & Devices Market Estimates & Forecasts, 2024-2035
Table 14. Italy Ophthalmology Drugs & Devices Market Estimates & Forecasts, 2024-2035
Table 15. Rest Of Europe Ophthalmology Drugs & Devices Market Estimates & Forecasts, 2024-2035
Table 16. China Ophthalmology Drugs & Devices Market Estimates & Forecasts, 2024-2035
Table 17. India Ophthalmology Drugs & Devices Market Estimates & Forecasts, 2024-2035
Table 18. Japan Ophthalmology Drugs & Devices Market Estimates & Forecasts, 2024-2035
Table 19. Australia Ophthalmology Drugs & Devices Market Estimates & Forecasts, 2024-2035
Table 20. South Korea Ophthalmology Drugs & Devices Market Estimates & Forecasts, 2024-2035
………….
List of Figures
Fig 1. Global Ophthalmology Drugs & Devices Market, Research Methodology
Fig 2. Global Ophthalmology Drugs & Devices Market, Market Estimation Techniques
Fig 3. Global Market Size Estimates & Forecast Methods
Fig 4. Global Ophthalmology Drugs & Devices Market, Key Trends 2025
Fig 5. Global Ophthalmology Drugs & Devices Market, Growth Prospects 2024-2035
Fig 6. Global Ophthalmology Drugs & Devices Market, Porter’s Five Forces Model
Fig 7. Global Ophthalmology Drugs & Devices Market, PESTEL Analysis
Fig 8. Global Ophthalmology Drugs & Devices Market, Value Chain Analysis
Fig 9. Ophthalmology Drugs & Devices Market By Treatment, 2025 & 2035
Fig 10. Ophthalmology Drugs & Devices Market By Product, 2025 & 2035
Fig 11. Ophthalmology Market By Treatment Sub-segments, 2025 & 2035
Fig 12. Ophthalmology Market By Drugs vs Devices, 2025 & 2035
Fig 13. Ophthalmology Market By Surgical vs Non-surgical Modalities, 2025 & 2035
Fig 14. North America Ophthalmology Market, 2025 & 2035
Fig 15. Europe Ophthalmology Market, 2025 & 2035
Fig 16. Asia Pacific Ophthalmology Market, 2025 & 2035
Fig 17. Latin America Ophthalmology Market, 2025 & 2035
Fig 18. Middle East & Africa Ophthalmology Market, 2025 & 2035
Fig 19. Global Ophthalmology Drugs & Devices Market, Company Market Share Analysis (2025)
